HIV-1 Infected Patients, Phase II Trial, Dual Combination Doravirine/Raltegravir Open Label
Condition(s):HIV InfectionsLast Updated:November 30, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):HIV InfectionsLast Updated:November 30, 2023Recruiting
Condition(s):Adverse EffectsLast Updated:March 27, 2012Completed
Condition(s):Pain; Neuropathy;PeripheralLast Updated:October 4, 2022Recruiting
Condition(s):Alzheimer DiseaseLast Updated:August 1, 2023Recruiting
Condition(s):Type 2 Diabetes MellitusLast Updated:November 18, 2023Terminated
Condition(s):Alcohol Drinking; Violence in AdolescenceLast Updated:August 18, 2023Completed
Condition(s):StrokeLast Updated:September 26, 2019Completed
Condition(s):Helicobacter Pylori Infection; Post-Treatment; EfficacyLast Updated:May 6, 2023Recruiting
Condition(s):Skin GraftLast Updated:September 8, 2023Active, not recruiting
Condition(s):IgA NephropathyLast Updated:February 10, 2022Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.